Table 1.

Clinical characteristics of patients at baseline

	CPP (n = 65)		PCP (n = 65)
	Mean	95 % CI	Mean	95 % CI	p-value
BMI	31.2	29.4–33.0	31.0	29.3–32.6	0.85
Average 10 year CVD risk	23.3	18.1–28.5	22.7	17.8–27.7	0.80
Systolic Blood Pressure Average	132.4	127.3–137.5	136.6	131.2–142.0	0.27
Total Cholesterol	184.2	169.4–199.0	182.4	168.0–196.8	0.86
High Density Lipoprotein	51.2	46.6–55.8	53.3	48.2–58.3	0.55
Hemoglobin A1c	7.5	6.8–8.2	6.8	6.2–7.3	0.02
Brief Pain Inventory Score	7.2	6.2–8.2	6.5	5.0–8.0	0.37
Outpatient Visitsa	20.6	18.2–22.9	13.2	10.5–15.9	0.0002
Primary Care Provider Visits	15.0	12.9–17.1	13.2	10.5–15.9	0.32
Clinical Pharmacist Practitioner Visitsb	5.6	4.6–6.7	0	N/A	N/A
Emergency Department Visitsc	1.7	1.2–2.3	2.9	1.7–4.1	0.06
Emergency Department Visits related to HTN, DM, Paind	0.25	0.1–0.4	0.52	0.10–0.95	0.20
Inpatient Admissionse	1.4	0.8–1.9	1.8	1.0–2.6	0.32
Inpatient Admissions related to HTN, DM, Painf	0.5	0.1–0.9	0.4	0.2–0.5	0.51

^aTotal outpatient visits: CPP cohort 1338 visits; PCP cohort 858 visits

^bPatients in the PCP cohort did not receive treatment from CPPs, therefore, there were no CPP visits in the PCP, and a p-value was unable to be calculated

^cEmergency Department visits: CPP 115 ED visits; PCP 190 ED visits

^dEmergency Department visits related to HTN, DM, Pain: CPP 16 ED visits; PCP 34 ED visits

^eInpatient Admissions: CPP 88 IA; PCP 117 IA

^fInpatient Admissions related to HTN, DM, Pain: CPP 32 IA; PCP 23 IA